Comparative analysis of the single-molecule transport kinetics of OATP1B1 genetic variants

被引:0
作者
Tsujii, Kazunari [1 ]
Yajima, Kodai [1 ]
Akiyoshi, Takeshi [1 ,2 ]
Sakamoto, Kazuho [7 ]
Suzuki, Yoshiaki [4 ]
Oka, Takayuki [5 ]
Imaoka, Ayuko [1 ]
Yamamura, Hisao [4 ]
Kurokawa, Junko [3 ]
Ohtani, Hisakazu [1 ,2 ,6 ]
机构
[1] Keio Univ, Grad Sch Pharmaceut Sci, Div Clin Pharm, 1-5-30 Shibakoen, Minato Ku, Tokyo 1058512, Japan
[2] Keio Univ, Sch Med, Dept Clin Pharm, 35 Shinanomachi, Shinjuku Ku, Tokyo 1608582, Japan
[3] Univ Shizuoka, Sch Pharmaceut Sci, Dept Bioinformat Pharmacol, 52-1 Yada, Suruga Ku, Shizuoka, Shizuoka 4228526, Japan
[4] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, 3-1 Tanabedori, Mizuho Ku, Nagoya 4678603, Japan
[5] Tokyo Lab, Nan Technol Japan KK, Wakamatsu Cho, Shinjuku Ku, Tokyo 1620056, Japan
[6] Keio Univ Hosp, Dept Pharm, 35 Shinanomachi, Shinjuku Ku, Tokyo 1608582, Japan
[7] Int Univ Hlth & Welf, Sch Pharm, 2600-1 Kitakanemaru, Otawara, Tochigi 3248501, Japan
关键词
Transporter; Intrinsic activity; Patch clamp; BK channel; POLYMORPHISMS; VARIABILITY; EXPRESSION; DRUG; DISPOSITION; PRAVASTATIN;
D O I
10.1016/j.jphs.2025.04.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several genetic variants of OATP1B1, a hepatic uptake transporter, increase the blood concentrations of substrate drugs, e.g., *15 carriers exhibit higher blood substrate concentrations than *1b carriers. It remains unclear whether these differences are due to changes in expression or intrinsic activity (transport activity per OATP1B1 molecule). This study compared the intrinsic activity of four OATP1B1 variants, *1a, *1b, *5, and *15, using HEK293 cell lines that co-expressed large-conductance Ca2+-activated K+ (BK) channels and one of the OATP1B1 variants. To estimate the kinetic parameters Km and Vmax, 2 ', 7 '-dichlorofluorescein uptake was evaluated. The number of OATP molecules per cell (QT) was calculated from BK channel-mediated whole-cell conductance and the OATP1B1/BK channel expression ratio (rho) (determined by LC-MS/MS). Vmax,int (maximum intrinsic transport velocity) was obtained by dividing Vmax by QT, and intrinsic clearance (CLint) was calculated as Vmax,int/Km. The Km values of *1a, *1b, *5, and *15 were 12.5, 9.19, 7.53, and 10.4 mu M, and their Vmax,int values were 3.0, 7.0, 1.5, and 1.2 x 10-21 mol/OATP molecule/min, respectively. Accordingly, the CLintvalue for OATP1B1*15 was 15 % lower than that for OATP1B1*1b, suggesting that the increased blood substrate concentrations observed in OATP1B1*15 carriers may be due to the decreased intrinsic activity of OATP1B1*15.
引用
收藏
页码:166 / 171
页数:6
相关论文
共 32 条
[1]   CELLULAR FRACTIONATION AND ISOLATION OF THE PLASMA-MEMBRANE OF BURKITTS-LYMPHOMA CELLS [J].
BOLAND, JD ;
TWETO, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 600 (03) :713-729
[2]   Detection of the human organic anion transporters SLUM (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma [J].
Cui, YH ;
König, J ;
Nies, AT ;
Pfannschmidt, M ;
Hergt, M ;
Franke, WW ;
Alt, W ;
Moll, R ;
Keppler, D .
LABORATORY INVESTIGATION, 2003, 83 (04) :527-538
[3]   The superfamily of organic anion transporting polypeptides [J].
Hagenbuch, B ;
Meier, PJ .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2003, 1609 (01) :1-18
[4]   Lost in Centrifugation: Accounting for Transporter Protein Losses in Quantitative Targeted Absolute Proteomics [J].
Harwood, Matthew D. ;
Russell, Matthew R. ;
Neuhoff, Sibylle ;
Warhurst, Geoffrey ;
Rostami-Hodjegan, Amin .
DRUG METABOLISM AND DISPOSITION, 2014, 42 (10) :1766-1772
[5]   Drug and bile acid transporters in rosuvastatin hepatic uptake: Function, expression, and pharmacogenetics [J].
Ho, Richard H. ;
Tirona, Rommel G. ;
Leake, Brenda F. ;
Glaeser, Hartmut ;
Lee, Wooin ;
Lemke, Christopher J. ;
Wang, Yi ;
Kim, Richard B. .
GASTROENTEROLOGY, 2006, 130 (06) :1793-1806
[6]   Molecular basis of pimarane compounds as novel activators of large-conductance Ca2+-activated K+ channel α-subunit [J].
Imaizumi, Y ;
Sakamoto, K ;
Yamada, A ;
Hotta, A ;
Ohya, S ;
Muraki, K ;
Uchiyama, M ;
Ohwada, T .
MOLECULAR PHARMACOLOGY, 2002, 62 (04) :836-846
[7]   Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C) [J].
Iwai, M ;
Suzuki, H ;
Ieiri, I ;
Otsubo, K ;
Sugiyama, Y .
PHARMACOGENETICS, 2004, 14 (11) :749-757
[8]   Investigation of Fluorescein Derivatives as Substrates of Organic Anion Transporting Polypeptide (OATP) 1B1 To Develop Sensitive Fluorescence-Based OATP1B1 Inhibition Assays [J].
Izumi, Saki ;
Nozaki, Yoshitane ;
Komori, Takafumi ;
Takenaka, Osamu ;
Maeda, Kazuya ;
Kusuhara, Hiroyuki ;
Sugiyama, Yuichi .
MOLECULAR PHARMACEUTICS, 2016, 13 (02) :438-448
[9]   Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells [J].
Kameyama, Y ;
Yamashita, K ;
Kobayashi, K ;
Hosokawa, M ;
Chiba, K .
PHARMACOGENETICS AND GENOMICS, 2005, 15 (07) :513-522
[10]   The Effects of N-Glycosylation on the Expression and Transport Activity of OATP1A2 and OATP2B1 [J].
Kataoka, Hiroki ;
Akiyoshi, Takeshi ;
Uchida, Yasuo ;
Imaoka, Ayuko ;
Terasaki, Tetsuya ;
Ohtani, Hisakazu .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 113 (05) :1376-1384